Point: Mammography screening—sticking to the science

Current Oncology

Volumn 22, Issue 3, 2015, Pages 174-176

  Yaffe, Martin J ^a  

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER SCREENING; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAMMOGRAPHY; META ANALYSIS (TOPIC); MORTALITY; NOTE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

EID: 84931466937     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.22.2371     Document Type: Note

References (25)

1. Independent U.K. Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778–86.
2. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727–37,W237–42.
3. Hendrick RE, Smith RA, Rutledge JH , Smart CR. Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;:87–92.
4. Duffy SW, Yen AMF, Chen TH, et al. Long-term benefits of breast screening. Breast Cancer Manag 2012;1:31–8.
5. Coldman A, Phillips N. Population studies of the effectiveness of mammographic screening. Prev Med 2011;53:115–17.
6. Coldman A, Phillips N, Wilson C, et al. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst 2014;106:dju261.
7. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992;147:1459–76. [Erratum in: CMAJ 1993;148:718]
8. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992;147:1477–88. [Erratum in: CMAJ 1993;148:718]
9. Narod SA. Reflections on screening mammography and the early detection of breast cancer. Curr Oncol 2014;21:210–14.
10. Boyd NF, Jong RA, Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ. A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology 1993;189:661–3.
11. Kopans DB. The Canadian Screening Program: a different perspective. AJR Am J Roentgenol 1990;155:748–9.
12. Burhenne LJ, Burhenne HJ. The Canadian National Breast Screening Study: a Canadian critique. AJR Am J Roentgenol 1993;161:761–3.
13. Baum M. Re: Reflections on screening mammography and the early detection of breast cancer. Curr Oncol 2014;21:215–16.
14. Foulkes WD. Screening mammography: the turning of the tide? Curr Oncol 2014;21:205–7.
15. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137:305–12.
16. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50–59 years. J Natl Cancer Inst 2000;92:1490–9.
17. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ 2014;348:g366.
18. Boyd NF. The review of randomization in the Canadian National Breast Screening Study. Is the debate over? CMAJ 1997;156:207–9.
19. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995;75:997–1003.
20. Morrison AS. Intermediate determinants of mortality in the evaluation of screening. Int J Epidemiol 1991;20:642–50.
21. Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol 1993;161:755–60.
22. Yaffe MJ. Correction: Canada Study [letter]. J Natl Cancer Inst 1993;85:94.
23. Smith RA. Counterpoint: overdiagnosis in breast cancer screening. J Am Coll Radiol 2014;11:648–52.
24. Miller AB. Re: “Counterpoint: overdiagnosis in breast cancer screening.” J Am Coll Radiol 2014;11:923.
25. Smith RA. Re: “Counterpoint: overdiagnosis in breast cancer screening” [author’s reply]. J Am Coll Radiol 2014;11:923–4.